MetaADEDB 2.0 @ LMMD
Codeine
(WUXLCJZUUHIXFY-FFHNEAJVSA-N)
Structure
SMILES
OP(=O)(O)O.COc1ccc2c3c1O[C@@H]1[C@@]43CCN([C@H](C2)[C@@H]4C=C[C@@H]1O)C
Molecular Formula:
C18H24NO7P
Molecular Weight:
397.359
Log P:
0.5104
Hydrogen Bond Acceptor:
8
Hydrogen Bond Donor:
4
TPSA:
129.5
CAS Number(s):
52-28-8
Synonym(s)
1.
Codeine
2.
Ardinex
3.
Codeine Phosphate
4.
Isocodeine
5.
N-Methylmorphine
6.
N Methylmorphine
External Link(s)
MeSHD003061
PubChem Compound5359227
CHEMBLCHEMBL1159819
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1OverdoseFAERS: 4US FAERS
2NauseaFAERS: 3
Canada Vigilance: 7
Canada Vigilance
US FAERS
3PancreatitisFAERS: 3US FAERS
4Toxicity to various agentsFAERS: 3US FAERS
5VomitingFAERS: 3
Canada Vigilance: 9
Canada Vigilance
US FAERS
6Carbon Monoxide PoisoningFAERS: 2US FAERS
7Completed SuicideFAERS: 2US FAERS
8ConstipationFAERS: 2US FAERS
9MalaiseFAERS: 2US FAERS
10Abdominal PainFAERS: 1
Canada Vigilance: 3
Canada Vigilance
US FAERS
11Accidental overdoseFAERS: 1US FAERS
12Acute kidney injuryFAERS: 1US FAERS
13Anaphylactic shockFAERS: 1US FAERS
14Chest PainFAERS: 1
Canada Vigilance: 2
Canada Vigilance
US FAERS
15Drug DependenceFAERS: 1US FAERS
16DystoniaFAERS: 1US FAERS
17Feeling abnormalFAERS: 1US FAERS
18HemiparesisFAERS: 1US FAERS
19Hyporesponsive to stimuliFAERS: 1US FAERS
20MiliariaFAERS: 1US FAERS
21Neck PainFAERS: 1US FAERS
22Respiratory DepressionFAERS: 1US FAERS
23Respiratory FailureFAERS: 1US FAERS
24SepsisFAERS: 1US FAERS
25Sphincter of Oddi DysfunctionFAERS: 1US FAERS
26SyncopeFAERS: 1US FAERS
27UrticariaFAERS: 1
Canada Vigilance: 19
Canada Vigilance
US FAERS
28Abdominal discomfortCanada Vigilance: 3Canada Vigilance
29AkathisiaCanada Vigilance: 1Canada Vigilance
30AngioedemaCanada Vigilance: 3Canada Vigilance
31AstheniaCanada Vigilance: 5Canada Vigilance
32BlindnessCanada Vigilance: 1Canada Vigilance
33BradycardiaCanada Vigilance: 1Canada Vigilance
34BronchospasmCanada Vigilance: 2Canada Vigilance
35Chest discomfortCanada Vigilance: 1Canada Vigilance
36DermatitisCanada Vigilance: 2Canada Vigilance
37DizzinessCanada Vigilance: 3Canada Vigilance
38DyspepsiaCanada Vigilance: 1Canada Vigilance
39ErythemaCanada Vigilance: 18Canada Vigilance
40FatigueCanada Vigilance: 1Canada Vigilance
41FlushingCanada Vigilance: 17Canada Vigilance
42HypersensitivityCanada Vigilance: 1Canada Vigilance
43HypotensionCanada Vigilance: 4Canada Vigilance
44Injection Site ReactionCanada Vigilance: 30Canada Vigilance
45Injection site inflammationCanada Vigilance: 9Canada Vigilance
46NervousnessCanada Vigilance: 1Canada Vigilance
47PallorCanada Vigilance: 1Canada Vigilance
48PalpitationsCanada Vigilance: 6Canada Vigilance
49PruritusCanada Vigilance: 11Canada Vigilance
50PurpuraCanada Vigilance: 1Canada Vigilance
51Rash erythematousCanada Vigilance: 21Canada Vigilance
52Respiratory arrestCanada Vigilance: 1Canada Vigilance
53TachycardiaCanada Vigilance: 2Canada Vigilance
54TinnitusCanada Vigilance: 1Canada Vigilance
55Urinary RetentionCanada Vigilance: 1Canada Vigilance
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120329

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.